| α-GalCer | α-Galactosylceramide |
| AIH | Autoimmune hepatitis |
| ALF | Acute liver failure |
| APAF-1 | Apoptotic peptidase activating factor-1 |
| APAP | Acetaminophen |
| AQ | Amodiaquine |
| ASK1 | Apoptosis signal regulating kinase 1 |
| ATG | Autophagy |
| ATP | Adenosine triphosphate |
| Bax | Bcl-2-like protein 4 |
| Bcl-2 | B-cell lymphoma 2 |
| c-FLIP | FLICE inhibitory protein |
| CD4 | Cluster of differentiation 4 |
| CD8 | Cluster of differentiation 8 |
| CD95 | Cluster of differentiation 95, also known as the FAS receptor |
| cIAP1/2 | Cellular inhibitor of apoptosis 1/2 |
| Con A | Concanavalin A |
| CTLA4 | Cytotoxic T-lymphocyte-associated protein 4 |
| CYP | Cytochrome P450 |
| DILI | Drug-induced liver injury |
| DILIN | Drug-Induced Liver Injury Network |
| DNA | Deoxyribonucleic acid |
| DOK4 | Docking protein 4 |
| DR | Death receptors |
| ER | Endoplasmic reticulum |
| ETC | Electron transport chain |
| FADD | Fas-associated protein with death domain |
| FasL | Fas ligand |
| Fer-1 | Ferrostatins |
| FLICE | Fas-associating protein with death domain-like interleukin-1 β-converting enzyme |
| GalN | D-galactosamine |
| GPX4 | Glutathione peroxidase 4 |
| GSDMD | Gasdermin D |
| GSH | Glutathione |
| GSK3β | Glycogen synthase kinase 3 β |
| GST1 | Glutathione-S-transferase |
| GWAS | Genome-wide association studies |
| HDS | Herbal and dietary supplements |
| HLA | Human leukocyte antigen |
| HSC | Hepatic stellate cells |
| IDILI | Idiosycratic drug-induced liver injury |
| IFNγ | Interferon γ |
| IL-10 | Interleukin 10 |
| INH | Isoniazide |
| iNOS | Inducible nitric oxide synthase |
| iPSC | Induced pluripotent stem cell |
| JAK | Janus kinase |
| JNK | c-Jun terminal kinase |
| KC | Kupffer cells |
| LPO | Lipid peroxidation |
| LPS | Lipopolysaccharide |
| LSECs | Liver sinusoidal endothelial cells |
| MAPK | Mitogen-activated protein kinases |
| MHC | Major histocompatibility complex |
| MiR | micro RNA |
| MKK4 | Mitogen-activated protein kinase kinase 4 |
| MLK3 | Mixed-lineage kinase 3 |
| MLKL | Mixed lineage domain like |
| MOMP | Mitochondrial outer membrane permeabilization |
| MPT | Membrane permeability transition |
| NAPQI | N-acetyl-p-benzoquinoneimine |
| Nec | Necrostatins |
| NFκB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NK | Natural killer cells |
| NKT | Natural killer T cells |
| NOS | Nitric oxide synthase |
| NPC | Non-parenchymal cells |
| PD1 | Programmed cell death protein 1 |
| PKCα | Protein kinase C α |
| PHH | Primary human hepatocytes |
| PMH | Primary mouse hepatocytes |
| PTPN6 | Protein tyrosine phosphatase type 6 |
| RHIM | RIP homology interaction motif |
| RIPK1/RIP1 | Receptor interacting serine/threonine kinase 1 |
| RIPK3/RIP3 | Receptor interacting serine/threonine kinase 3 |
| ROS | Reactive oxygen species |
| Sab | SH3 binding protein 5 |
| SEB | Super-antigen staphylococcal enterotoxin B |
| SJS | Stevens–Johnson syndrome |
| STAT | Signal transducer and activator of transcription |
| STAT1 | Signal transducer and activator of transcription 1 |
| SULT2A1 | sulfotransferase 2A1 |
| T-regs | Regulatory T cells |
| TAB2/3 | TAK1-binding protein 2/3 |
| TAK1 | Transforming growth factor-β-activated kinase 1 |
| tBid | Cleaved Bid |
| TCR | T cell receptor |
| TEN | Toxic epidermal necrosis |
| TGFβ | Transforming growth factor β |
| TNF | Tumor necrosis factor |
| TNFR1 | Tumor necrosis factor receptor 1 |
| TNFα | Tumor necrosis factor α |
| TRADD | TNFR-associated death domain |
| TRAF2/5 | TNFR-associated factor 2/ 5 |
| TRAIL-R1/R2 | TNF-related apoptosis-inducing ligand receptor 1/2 |
| UPR | Unfolded protein response |
| WT | Wild type |